
    
      Subjects will be randomized to one of two groups: one group will take 500 mg of the
      investigational product (IHBG-10) 15 minutes prior to the three main meals of the day; the
      other group will take placebo 15 minutes prior to the three main meals of the day. Subjects
      will be on the investigational product or placebo for 12 weeks. Participation in this study
      involves four study visits.
    
  